DMAC vs MPC · $157.4M cap vs P/E 16, rev $138.86B
DiaMedica Therapeutics Inc (DMAC) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
DMAC currently screens at market cap $157.4M. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the DMAC and MPC stock pages for the full models.
Not investment advice.